Dermavon Holdings Limited
Clinical trials sponsored by Dermavon Holdings Limited, explained in plain language.
-
New psoriasis pill shows promise in major trial
Disease control Not yet recruitingThis study tests a new tablet called CMS-D001 for adults with moderate to severe plaque psoriasis. About 540 people will take either the drug or a placebo to see if it improves skin symptoms like redness and scaling. The goal is to find a safe and effective treatment option.
Phase: PHASE2, PHASE3 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Not yet recruitingThis study tests a new medicine called CMS-D001 for adults with moderate to severe eczema (atopic dermatitis) who haven't gotten enough relief from standard creams. About 160 people will receive either the drug or a placebo to see if it improves skin symptoms like redness and itc…
Phase: PHASE2 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated May 08, 2026 12:01 UTC